Ask AI
ProCE Banner Activity

Benefits and Barriers in Transitioning to Injectable PrEP: My Story

Clinical Thought

It was a personal loss that motivated me to take control of my sexual health with PrEP. Here’s what the transition to an injectable form was like for me.

Released: February 19, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from ViiV Healthcare.

ViiV Healthcare

Target Audience

This activity is intended for United States physicians, pharmacists, nurses, advanced practice providers, and other healthcare professionals who provide antiretroviral therapy for people living with HIV and/or PrEP for people who may benefit from it.

Program Learning Goal

The goal of this activity is to improve healthcare professionals’ competence in adopting LA ART and LA PrEP into routine clinical practice by delivering targeted education that increases awareness of these agents’ clinical value and equips learners with practical strategies for navigating payer requirements, coordinating specialty pharmacy workflows, and integrating injection visits into sustainable care models.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Recognize the value of LA PrEP and the positive impact it may offer to recipients

Disclosure

Primary Author

Colleen F. Kelley, MD, MPH: researcher: Gilead, Merck, ViiV.